期刊
EXPERT OPINION ON INVESTIGATIONAL DRUGS
卷 -, 期 -, 页码 -出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/13543784.2023.2276755
关键词
Baxdrostat; aldosterone synthase inhibitors; essential hypertension; treatment-resistant hypertension; primary hyperaldosteronism
This article introduces Baxdrostat, a novel medication that targets aldosterone synthesis to mitigate the negative effects of hypertension. It showcases rapid absorption, high oral bioavailability, and significant selectivity for aldosterone synthase, making it a promising antihypertensive agent. Early trials have shown its potential in reducing blood pressure, and current clinical trials are exploring its application in other conditions such as primary aldosteronism and chronic kidney disease.
IntroductionHypertension, a global health concern, poses a significant risk for other cardiovascular diseases. While lifestyle modifications and interventions like the Dietary Approaches to Stop Hypertension (DASH) diet offer some respite, their maintenance can be challenging. Recently, the spotlight has turned toward the renin-angiotensin-aldosterone system, a crucial player in the pathophysiology of hypertension. Contrary to other drugs, Baxdrostat, an innovative aldosterone synthase inhibitor (ASI), targets aldosterone synthesis, mitigating negative systemic effects.Areas coveredBaxdrostat showcases rapid absorption, high oral bioavailability, and significant selectivity for aldosterone synthase which presents a proactive approach to hypertension management by reducing aldosterone levels. Early trials have demonstrated its potential in lowering blood pressure in resistant hypertension cases. Current clinical trials are also exploring its application in primary aldosteronism and chronic kidney disease, with preliminary findings indicating its promise as a novel antihypertensive agent. This article encapsulates the current state of knowledge regarding Baxdrostat, encompassing its uses, ongoing clinical trials, and potential future clinical applications.Expert opinionFuture research endeavors will play a pivotal role in unveiling the effectiveness and safety profile of this novel medication. Thus, positioning the baxdrostat as a valuable addition to the armamentarium of antihypertensive agents, especially for patients with complex, multifactorial hypertensive conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据